Wissel Janne LT 4
4 · JAZZ PHARMACEUTICALS INC · Filed Dec 8, 2010
Insider Transaction Report
Form 4
Wissel Janne LT
SVP, Chief Regulatory Officer
Transactions
- Sale
Common Stock
2010-12-07$18.75/sh−500$9,375→ 106,721 total - Sale
Common Stock
2010-12-08$18.38/sh−59,500$1,093,610→ 47,221 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.36 to $18.41, inclusive.
- [F2]The reporting person undertakes to provide to Jazz Pharmaceuticals, Inc., any security holder of Jazz Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4.